Related Experiment Video
Updated: Sep 12, 2025
08:27
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.7K
A modular polymer platform for efficient mRNA delivery in cancer immunotherapy
Guanyou Lin1, Jianxi Huang1, Xinqi Li1
1Department of Materials Science and Engineering, University of Washington, Seattle, Washington 98195, USA. mzhang@uw.edu.
Nanoscale Horizons
|August 7, 2025
Summary
A novel polymeric nanoplatform, PFHA-PEI-mRNA-HP, enhances messenger RNA (mRNA) delivery for cancer gene therapy. This platform shows superior efficiency and stability compared to lipid nanoparticles (LNPs), significantly inhibiting tumor growth in preclinical models.
Area of Science:
- Biotechnology and Nanomedicine
- Gene Therapy Delivery Systems
Background:
- Messenger RNA (mRNA) therapies for cancer and viral infections require effective delivery systems due to mRNA's instability.
- Current lipid nanoparticles (LNPs) face limitations in safety, storage, and cost, driving the need for alternative platforms.
- Polymeric delivery systems offer structural versatility and high transfection efficiency, presenting a promising alternative to LNPs.
Purpose of the Study:
- To develop and evaluate a novel polymeric mRNA delivery nanoplatform, PFHA-PEI-mRNA-HP, for enhanced therapeutic efficacy.
- To investigate the impact of simultaneous fluorination and heparinization of polyethylenimine (PEI) on mRNA complex performance.
- To assess the in vitro and in vivo efficacy of PFHA-PEI-mRNA-HP for cancer gene therapy.
Main Methods:
- Simultaneous fluorination and heparinization of low molecular weight polyethylenimine (PEI)-based mRNA complexes to create PFHA-PEI-mRNA-HP.
- Evaluation of physicochemical properties, cellular uptake, endosomal escape, and biocompatibility of the nanoplatform.
- In vitro transfection efficiency assessment across multiple cancer cell lines and comparison with Lipofectamine 2000.
- In vivo studies using a triple-negative breast cancer mouse model with IL12 mRNA delivery combined with anti-PD-L1 therapy.
Main Results:
- PFHA-PEI-mRNA-HP demonstrated ultra-high transfection efficiency (>90%) in various cancer cell types, surpassing Lipofectamine 2000.
- The nanoplatform exhibited significantly improved stability compared to Lipofectamine 2000 during storage above 0 °C for 15 days.
- In vivo administration of IL12 mRNA via PFHA-PEI-mRNA-HP, combined with anti-PD-L1, effectively inhibited tumor growth without toxicity.
Conclusions:
- PFHA-PEI-mRNA-HP represents a highly efficient and stable polymeric nanoplatform for mRNA delivery.
- The modifications to the PEI backbone enhance mRNA complex performance, leading to superior transfection and therapeutic outcomes.
- This nanoplatform holds significant potential as a reliable tool for advancing mRNA-based cancer gene therapies.
Related Concept Videos
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
02:15Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
01:30Cancer Vaccines
510
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
510